Cognition Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.About CGTX
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions.
CGTX Key Statistics
Stock Snapshot
As of today, Cognition Therapeutics(CGTX) shares are valued at $1.05. The company's market cap stands at 100.8M, with a P/E ratio of -5.37.
As of 2026-09-04, Cognition Therapeutics(CGTX) stock has fluctuated between $1.02 and $1.06. The current price stands at $1.05, placing the stock +2.8% above today's low and -1.5% off the high.
Cognition Therapeutics(CGTX) shares are trading with a volume of 261.44K, against a daily average of 333.28K.
During the past year, Cognition Therapeutics(CGTX) stock moved between $0.55 at its lowest and $2.67 at its peak.
During the past year, Cognition Therapeutics(CGTX) stock moved between $0.55 at its lowest and $2.67 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.